Dr. Kristyn Anne Mannoia, MD

Dr. Mannoia practices at Riverside University Medical Center in Moreno Valley, California.

Dr. Mannoia's NPI, 1184910762, was assigned on June 22, 2011. Dr. Mannoia graduated from Loma Linda University School Of Medicine in 2011. Dr. Mannoia holds California license A124962.

Dr. Mannoia's primary practice is Riverside University Medical Center, at 26520 Cactus Ave, Moreno Valley, CA 92555 in Riverside County. The practice phone is (951) 486-4458.

Dr. Mannoia's primary practice is Riverside University Medical Center in Moreno Valley, California. Dr. Mannoia is also affiliated with Riverside University Health System - Medical Center. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Mannoia to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mannoia practices. Vendor and product names are available with a free account.

Vascular surgery is Dr. Mannoia's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Mannoia is board certified in surgery by the American Board of Surgery. Dr. Mannoia is licensed in California.

Dmand AI lists amputation, circulatory problems in extremities, deep vein thrombosis (DVT), heart device and aorta surgery, leg revascularization, peripheral vascular disease and varicose veins among the conditions Dr. Mannoia treats.

CMS data shows 170 Medicare services from Dr. Mannoia across 5 procedure codes in 2024, for 150 Medicare patients. Medicare paid $9,916 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 150 Medicare patients who saw Dr. Mannoia in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 86% are also on Medicaid. Their average risk score is 3.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mannoia's median patient age at 60, with 60% women.

In 2024, Dr. Mannoia wrote 70 Medicare Part D claims for 30 patients. 84% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $84 in total drug cost. In 2023, CMS named 64 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Mannoia for performance year 2024, reported as part of a group. Dr. Mannoia accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Mannoia, published from 2016 to 2024. 2023 was the busiest year, with 3. The most frequent topics are Surgeons and Postoperative Complications. Dr. Mannoia has published most often in Ann Vasc Surg. Dr. Mannoia's most frequent co-authors are Sheela Thakor Patel, MD, Maksim Gusev, MD and Afshin M. Molkara, MD.

Dmand AI links Dr. Mannoia to 2 clinical trials. Conditions studied include Agnosia, Gangrene and Chronic Limb-Threatening Ischemia.

CMS Open Payments shows 90 general payments to Dr. Mannoia from 23 drug and device companies from 2016 to 2025. Grants make up the largest share, 70% of the total. Medtronic Vascular, Inc. paid the most, $15,100.

Dr. Mannoia graduated from Loma Linda University School Of Medicine in 2011. Dr. Mannoia is a member of ACS.

Dr. Mannoia is in network with 16 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.